These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. Chan JY; Walfish PG J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483 [TBL] [Abstract][Full Text] [Related]
10. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
11. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis. Weetman AP; Gunn C; Hall R; McGregor AM J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444 [TBL] [Abstract][Full Text] [Related]
12. Fc receptor-bearing blood mononuclear cells in thyroid disorders: increased levels in patients with subacute thyroiditis. Chartier B; Bandy P; Wall JR J Clin Endocrinol Metab; 1980 Nov; 51(5):1014-8. PubMed ID: 6968319 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of thyroid antigen-reactive T lymphocytes in the gland of patients with subacute thyroiditis. Tötterman TH; Gordin A; Häyry P; Andersson LC; Makinen T Clin Exp Immunol; 1978 Apr; 32(1):153-8. PubMed ID: 307462 [TBL] [Abstract][Full Text] [Related]
14. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274 [TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210 [TBL] [Abstract][Full Text] [Related]
17. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis. Chan JY; Walfish PG Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193 [TBL] [Abstract][Full Text] [Related]
18. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. Renné C; Ramos Lopez E; Steimle-Grauer SA; Ziolkowski P; Pani MA; Luther C; Holzer K; Encke A; Wahl RA; Bechstein WO; Usadel KH; Hansmann ML; Badenhoop K J Clin Endocrinol Metab; 2004 Nov; 89(11):5810-4. PubMed ID: 15531546 [TBL] [Abstract][Full Text] [Related]
19. Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. Valente WA; Vitti P; Rotella CM; Vaughan MM; Aloj SM; Grollman EF; Ambesi-Impiombato FS; Kohn LD N Engl J Med; 1983 Oct; 309(17):1028-34. PubMed ID: 6137770 [TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. Bogner U; Schleusener H; Wall JR J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]